Electrolyte
Calcium Gluconate 10%
Brand names: Calcium Gluconate 10% Injection
Adult dose
Dose: 10–30ml (2.25–6.75 mmol elemental calcium)
Route: IV over 5–10 min
Frequency: Repeat as clinically indicated; ECG-guided in hyperkalaemia
Max: 60ml per episode
Hyperkalaemia with ECG changes: 10–20ml IV over 5–10 min. Symptomatic hypocalcaemia: 10–20ml IV over 10 min. Tetany: 10ml IV over 5 min. Note: 10ml of 10% = 2.25 mmol elemental calcium.
Paediatric dose
Dose: 50 mg/kg
Route: IV slow over 5–10 min
Frequency: Single dose; repeat every 10 min if ECG changes persist
Max: 2000 mg
Concentration: 100 mg/ml
BNFc child 1 month–18 years: 0.5 mL/kg of 10% calcium gluconate IV over 5–10 min (max 20 mL = 2 g). Equivalent to 50 mg/kg of the 10% salt; provides ~4.5 mg/kg elemental calcium. Continuous ECG monitoring during administration; very irritant — use large vein, flush thoroughly. Ensure no concurrent ceftriaxone (calcium-ceftriaxone precipitate risk in neonates).
Paediatric weight-based calculator
BNFc child 1 month–18 years: 0.5 mL/kg of 10% calcium gluconate IV over 5–10 min (max 20 mL = 2 g). Equivalent to 50 mg/kg of the 10% salt; provides ~4.5 mg/kg elemental calcium. Continuous ECG monitoring during administration; very irritant — use large vein, flush thoroughly. Ensure no concurrent ceftriaxone (calcium-ceftriaxone precipitate risk in neonates).
Clinical pearls
- In hyperkalaemia: calcium stabilises the cardiac membrane (reduces threshold potential) within 1–3 min. Does NOT lower serum potassium — follow with insulin/dextrose.
- Calcium gluconate 10% is preferred over calcium chloride 10% for peripheral access — 3× less elemental calcium per 10ml but far less irritant if extravasated.
- Calcium chloride 10% (6.8 mmol/10ml) = 3× more elemental calcium than gluconate (2.25 mmol/10ml) — use chloride via central line in life-threatening emergencies.
- In digoxin toxicity: consider DigiFab (digoxin-specific antibody) instead of calcium — calcium risks precipitating asystole.
Contraindications
- Hypercalcaemia
- Digoxin toxicity (calcium potentiates toxic effects — risk of asystole)
- Severe hypophosphataemia (metastatic calcification risk)
Side effects
- Bradycardia and cardiac arrest with rapid IV injection
- Peripheral vasodilation, flushing
- Hypotension
- Tissue necrosis and venous thrombosis if extravasated
Interactions
- Sodium bicarbonate: precipitates — never in same IV line
- Digoxin: potentiates toxicity (avoid if possible — use digoxin-specific antibody fragments instead)
- Ceftriaxone: precipitates in neonates — do not co-administer via same line
Monitoring
- Continuous ECG
- serum calcium and potassium
- BP during infusion
Reference: BNFc; UK Renal Association Hyperkalaemia Guidelines 2020; NICE BNF 84. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- AmlodipineRecommendedDihydropyridine Calcium Channel Blocker
- VerapamilRecommendedNon-Dihydropyridine Calcium Channel Blocker
- DiltiazemRecommendedNon-Dihydropyridine Calcium Channel Blocker
Same class
Pathways
- Calcium channel blocker overdoseRecommendedTOXBASE/NPIS; AACT/EAPCCT; ESC; BNF
- β-blocker overdoseRecommendedTOXBASE/NPIS; AACT/EAPCCT; ESC; BNF
Same specialty
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines